Thursday, January 31, 2013
Pediatric Grand Rounds
(Conferences / Seminars / Lectures)
Advancing Therapy for Hemophilia A through Bioengineering
. Steven Pipe, MD
Professor Pediatrics & Pathology; Laurence A. Boxer Research Professor of Pediatrics and Communicable Diseases; Director Division of Pediatric Hematology and Oncology; Pediatric Medical Director, Hemophilia and Coagulation Disorders Program; Director, special Coagulation Laboratory; Director Fellowship Program in Pediatric Hematology/Oncology
University of Michigan, Ann Arbor, MI
At the end of the activity (presentation), the participants will be better able to:
1. Understand current therapy for hemophilia
2. Review the challenges and opportunities with current therapeutic approaches
3. Understand the mechanisms that limit factor VIII expression and activity
4. Review advancements in factor VIII therapeutics through bioengineering
The Michigan State University is accredited by the ACCME to provide continuing medical education for physicians.
The Michigan State University designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The target audience for this presentation includes department faculty, pediatric residents, medical students and community physicians.